The Experts below are selected from a list of 24 Experts worldwide ranked by ideXlab platform
Jefferson M Sesler - One of the best experts on this subject based on the ideXlab platform.
-
Intraosseous Drug Administration in children and adults during cardiopulmonary resuscitation
Annals of Pharmacotherapy, 2007Co-Authors: Marcia L Buck, Barbara S Wiggins, Jefferson M SeslerAbstract:Objective:To review and assess the available literature on the use of Intraosseous (IO) Drug Administration during cardiopulmonary resuscitation, addressing the benefits and risks of using this method of Drug delivery in children and adults.Data Sources:The MEDLINE (1950–July 2007) database was searched for pertinent abstracts, using the key term Intraosseous infusions. Additional references were obtained from the bibliographies of the articles reviewed. Manufacturer Web sites were used to obtain information about IO insertion devices.Study Selection and Data Extraction:All available English-language clinical trials, retrospective studies, and review articles describing IO Drug Administration were reviewed. Studies conducted in animal models to evaluate the effectiveness and safety of IO Drug Administration were also included.Data Synthesis:IO access uses the highly vascularized bone marrow to deliver fluids and medications during cardiopulmonary resuscitation. This route, developed in the 1940s, has been...
Marcia L Buck - One of the best experts on this subject based on the ideXlab platform.
-
Intraosseous Drug Administration in children and adults during cardiopulmonary resuscitation
Annals of Pharmacotherapy, 2007Co-Authors: Marcia L Buck, Barbara S Wiggins, Jefferson M SeslerAbstract:Objective:To review and assess the available literature on the use of Intraosseous (IO) Drug Administration during cardiopulmonary resuscitation, addressing the benefits and risks of using this method of Drug delivery in children and adults.Data Sources:The MEDLINE (1950–July 2007) database was searched for pertinent abstracts, using the key term Intraosseous infusions. Additional references were obtained from the bibliographies of the articles reviewed. Manufacturer Web sites were used to obtain information about IO insertion devices.Study Selection and Data Extraction:All available English-language clinical trials, retrospective studies, and review articles describing IO Drug Administration were reviewed. Studies conducted in animal models to evaluate the effectiveness and safety of IO Drug Administration were also included.Data Synthesis:IO access uses the highly vascularized bone marrow to deliver fluids and medications during cardiopulmonary resuscitation. This route, developed in the 1940s, has been...
Barbara S Wiggins - One of the best experts on this subject based on the ideXlab platform.
-
Intraosseous Drug Administration in children and adults during cardiopulmonary resuscitation
Annals of Pharmacotherapy, 2007Co-Authors: Marcia L Buck, Barbara S Wiggins, Jefferson M SeslerAbstract:Objective:To review and assess the available literature on the use of Intraosseous (IO) Drug Administration during cardiopulmonary resuscitation, addressing the benefits and risks of using this method of Drug delivery in children and adults.Data Sources:The MEDLINE (1950–July 2007) database was searched for pertinent abstracts, using the key term Intraosseous infusions. Additional references were obtained from the bibliographies of the articles reviewed. Manufacturer Web sites were used to obtain information about IO insertion devices.Study Selection and Data Extraction:All available English-language clinical trials, retrospective studies, and review articles describing IO Drug Administration were reviewed. Studies conducted in animal models to evaluate the effectiveness and safety of IO Drug Administration were also included.Data Synthesis:IO access uses the highly vascularized bone marrow to deliver fluids and medications during cardiopulmonary resuscitation. This route, developed in the 1940s, has been...
H. W. Gervais - One of the best experts on this subject based on the ideXlab platform.
-
What's new in cardiopulmonary resuscitation? American Heart Association
Anaesthesist, 1994Co-Authors: A. W. Prengel, K. H. Lindner, H. W. GervaisAbstract:A strong consensus was reached for several changes in the guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC) in the 1992 conference on CPR and ECC held by the Emergency Cardiac Care Committee of the American Heart Association. These new recommendations, together with differing recommendations of the European Resuscitation Council, are described. An unresponsive person with spontaneous respirations should be placed in the recovery position if no cervical trauma is suspected. Compared with endotracheal intubation, other airway-protecting devices such as combination esophageal-tracheal tubes are of minor acceptance. During ventilation, the time for filling the lungs is increased to 1.5 – 2 s to decrease the likelihood of gastric insufflation. Delivery of IV Drugs can be enhanced by an IV flush of sodium chloride. In endotracheal Drug Administration, higher doses and Drug dilution are recommended in infants and children up to 6 years of age, the value of Intraosseous Drug Administration is emphasized. For pulseless adult victims, the intitial dosage of epinephrine of 1 mg I.V. remains unchanged. For repeat doses, high-dose epinephrine up to 0.1 mg/kg is classified as of uncertain but possible efficacy. For lidocaine, the recommended I.V. dosage is 1.5 mg/kg. Sodium bicarbonate and calcium are not routinely recommended for resuscitation. For atropine, the maximum dose is 0.04 mg/kg. If hypomagnesaemia is present in recurrent and refractory ventricular fibrillation, it should be corrected by Administration of 1 to 2 mg magnesium sulfate I.V. Thrombolytic agents are classified as useful and effective in acute myocardial infarction and should be administered as early as possible. Glucose-containing fluids are discouraged for resuscitative efforts.
-
What's new on cardiopulmonary resuscitation?
1994Co-Authors: A. W. Prengel, K. H. Lindner, H. W. GervaisAbstract:A strong consensus was reached for several changes in the guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC) in the 1992 conference on CPR and ECC held by the Emergency Cardiac Care Committee of the American Heart Association. These new recommendations, together with differing recommendations of the European Resuscitation Council, are described. An unresponsive person with spontaneous respirations should be placed in the recovery position if no cervical trauma is suspected. Compared with endotracheal intubation, other airway-protecting devices such as combination esophageal-tracheal tubes are of minor acceptance. During ventilation, the time for filling the lungs is increased to 1.5 – 2 s to decrease the likelihood of gastric insufflation. Delivery of IV Drugs can be enhanced by an IV flush of sodium chloride. In endotracheal Drug Administration, higher doses and Drug dilution are recommended in infants and children up to 6 years of age, the value of Intraosseous Drug Administration is emphasized. For pulseless adult victims, the intitial dosage of epinephrine of 1 mg I.V. remains unchanged. For repeat doses, high-dose epinephrine up to 0.1 mg/kg is classified as of uncertain but possible efficacy. For lidocaine, the recommended I.V. dosage is 1.5 mg/kg. Sodium bicarbonate and calcium are not routinely recommended for resuscitation. For atropine, the maximum dose is 0.04 mg/kg. If hypomagnesaemia is present in recurrent and refractory ventricular fibrillation, it should be corrected by Administration of 1 to 2 mg magnesium sulfate I.V. Thrombolytic agents are classified as useful and effective in acute myocardial infarction and should be administered as early as possible. Glucose-containing fluids are discouraged for resuscitative efforts.
-
Was ist neu in der kardiopulmonalen Reanimation?
Der Anaesthesist, 1994Co-Authors: A. W. Prengel, K. h. Lindner, H. W. GervaisAbstract:Die 1992 von der American Heart Association geänderten Empfehlungen zur kardiopulmonalen Reanimation werden vorgestellt und den ebenfalls 1992 veröffentlichten Empfehlungen des European Resuscitation Council gegenübergestellt. Die stabile Seitenlage wird ausschließlich für Patienten ohne Zervikaltrauma empfohlen. Ösophagusobturator und Kombitubus sind gegenüber Endotrachealtubus nur bedingt geeignet. Unter Beatmung wird die Inspirationszeit auf 1,5 bis 2 s verlängert. Bei intravenöser Medikamentengabe wird ein nachfolgender NaCl-Bolus, bei endotrachealer Medikamentengabe eine Dosiserhöhung empfohlen. Für Kinder ist die intraossäre Medikamentengabe geeignet. Die Initialdosis von 1 mg Adrenalin i.v. wird für Erwachsene beibehalten. Wiederholungsgaben können bis zu 0,1 mg/kg dosiert werden. Für Lidocain beträgt die i.v.-Dosis 1,5 mg/kg. Natriumbikarbonat und Kalzium sind bei Reanimation keine Routinemedikamente, die Atropin-Höchstdosis beträgt 0,04 mg/kg. Bei refraktärem Kammerflimmern soll eine Hypomagnesiämie durch Magnesiumsulfatgabe ausgeglichen werden. Eine Thrombolyse ist bei akutem Myokardinfarkt indiziert und soll frühestmöglich erfolgen. Glukosehaltige Lösungen sollen nicht verwendet werden. A strong consensus was reached for several changes in the guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiac care (ECC) in the 1992 conference on CPR and ECC held by the Emergency Cardiac Care Committee of the American Heart Association. These new recommendations, together with differing recommendations of the European Resuscitation Council, are described. An unresponsive person with spontaneous respirations should be placed in the recovery position if no cervical trauma is suspected. Compared with endotracheal intubation, other airway-protecting devices such as combination esophageal-tracheal tubes are of minor acceptance. During ventilation, the time for filling the lungs is increased to 1.5 – 2 s to decrease the likelihood of gastric insufflation. Delivery of IV Drugs can be enhanced by an IV flush of sodium chloride. In endotracheal Drug Administration, higher doses and Drug dilution are recommended in infants and children up to 6 years of age, the value of Intraosseous Drug Administration is emphasized. For pulseless adult victims, the intitial dosage of epinephrine of 1 mg I.V. remains unchanged. For repeat doses, high-dose epinephrine up to 0.1 mg/kg is classified as of uncertain but possible efficacy. For lidocaine, the recommended I.V. dosage is 1.5 mg/kg. Sodium bicarbonate and calcium are not routinely recommended for resuscitation. For atropine, the maximum dose is 0.04 mg/kg. If hypomagnesaemia is present in recurrent and refractory ventricular fibrillation, it should be corrected by Administration of 1 to 2 mg magnesium sulfate I.V. Thrombolytic agents are classified as useful and effective in acute myocardial infarction and should be administered as early as possible. Glucose-containing fluids are discouraged for resuscitative efforts.
Tibballs J - One of the best experts on this subject based on the ideXlab platform.
-
Endotracheal and Intraosseous Drug Administration for paediatric CPR.
Australian Family Physician, 1992Co-Authors: Tibballs JAbstract:The endotracheal and Intraosseous routes are alternatives to the intravenous route of access to the circulation during emergency resuscitation. Adrenaline, lignocaine and atropine are readily absorbed from the respiratory tract via an endotracheal tube. All Drugs and resuscitative fluids can be infused into the tibial bone marrow using an Intraosseous needle.